KPV: Benefits, Dosage, Side Effects, and How to Get It in 2026
Medically reviewed by the Rite Aid Health Team · Last updated July 30, 2026
KPV is a three-amino-acid peptide studied for inflammation, gut health, immune response, and skin conditions. It forms part of alpha-MSH, a hormone involved in inflammatory signaling.
Almost done
We sent the first email to .
A quick confirmation helps ensure future updates reach the right inbox.
We also sent a verification text. Reply YES to confirm your phone number.
-
1
Confirm your email
Open the first email and click the confirmation link.
-
2
Only after step 1
Then your discount is reserved
Once you confirm, we reserve your discount and will notify you when peptide services launch.
The first email should arrive within a minute. Do not see it? Check spam or promotions.
Get 20% off your first compounded-peptide order
Join the early-access waitlist and we'll notify you the moment consultations and ordering open.
What is KPV?
KPV is a tripeptide made of three amino acids: lysine (K), proline (P), and valine (V). It is the C-terminal fragment of alpha-MSH (alpha-melanocyte-stimulating hormone), a naturally occurring hormone with anti-inflammatory activity.
KPV carries the anti-inflammatory action of the parent hormone in a much smaller, more stable molecule — small enough to be used orally, topically, or by injection.
Benefits and uses
What the research shows — the evidence base is anti-inflammatory and largely preclinical, which is the honest framing for KPV:
- Gut healing and inflammatory bowel conditions. The most-studied use. KPV has been studied in models of inflammatory bowel disease for its ability to calm intestinal inflammation and support healing of the gut lining.
- Immune modulation. It downregulates inflammatory signaling broadly, which is why it is studied as a general anti-inflammatory rather than for one tissue alone.
- Skin inflammation. Applied topically, KPV has been studied for inflammatory skin conditions and wound healing.
The gap between anecdote and human evidence is real. Most KPV data comes from cell and animal research; rigorous human clinical trials are limited. State that plainly rather than overselling.
How it works
KPV works inside the cell rather than only at a surface receptor. Once inside, it interferes with the NF-kB signaling pathway — the master switch the body uses to turn on inflammatory genes.
By downregulating that pathway, KPV reduces the production of inflammatory signals at the source. That intracellular mechanism is part of why it can be effective across the gut, the immune system, and the skin.
Dosage and administration
KPV is unusual among therapeutic peptides in that it is used by multiple routes — oral, topical, or subcutaneous injection — depending on the target.
Oral and topical forms are common for gut and skin uses; subcutaneous dosing is used for systemic anti-inflammatory effect. These are not official dosing guidelines — there is no FDA-approved KPV product — and dosing and route should be set by the prescribing provider.
For injectable use, reconstitution (mixing the lyophilized powder with bacteriostatic water) and drawing the right volume on an insulin syringe is where most people make errors.
For a peptide your clinician prescribed and an appropriate pharmacy prepared, use the peptide dosage calculator to convert the prescribed target dose into syringe units for your vial size.
Side effects and safety
KPV has shown a favorable safety profile in research, consistent with its small size and its origin as a fragment of a natural hormone. Reported effects in human use are generally mild.
The honest caveat: long-term human safety data does not exist. Anyone using KPV should work with a provider and monitor liver enzymes and kidney function on a cycle.
Legal status and how to get it in 2026
The FDA removed KPV from its Section 503A Category 2 list in April 2026.
On July 23 and 24, an FDA advisory committee recommended adding it to the Section 503A Bulks List. The committee considered wound healing and inflammatory conditions.
The vote was advisory. It was not drug approval, and the FDA has not made a final decision. Current access rules remain unchanged.
Products sold online for research use are not approved for human use. Their identity, strength, and quality may be uncertain.
Almost done
We sent the first email to .
A quick confirmation helps ensure future updates reach the right inbox.
We also sent a verification text. Reply YES to confirm your phone number.
-
1
Confirm your email
Open the first email and click the confirmation link.
-
2
Only after step 1
Then your discount is reserved
Once you confirm, we reserve your discount and will notify you when peptide services launch.
The first email should arrive within a minute. Do not see it? Check spam or promotions.
Get 20% off your first compounded-peptide order
Join the early-access waitlist and we'll notify you the moment consultations and ordering open.
KPV in the healing stack
KPV is the anti-inflammatory addition to the recovery stack built around BPC-157 and TB-500.
Where BPC-157 drives local repair and angiogenesis and TB-500 supports systemic cell migration, KPV calms the inflammation that accompanies injury and gut irritation. For the broader protocol, compare all three healing and recovery peptides.
Blood work to track KPV
KPV doesn't have a single direct biomarker, so tracking focuses on the inflammation it's meant to reduce and on safety:
- hs-CRP — a sensitive inflammation marker; useful to see whether systemic inflammation is trending down.
- Comprehensive metabolic profile — liver enzymes and kidney function, the safety baseline for any peptide cycle.
Test before you start and again at 4–6 weeks.
Baseline tests before a peptide cycle
Check safety and response markers before starting. These tests help establish a baseline for liver, kidney, glucose, hormone, and recovery tracking.
References
For general education only — not medical advice or a treatment recommendation. Peptides are not a substitute for care from a licensed provider. Talk to a qualified healthcare professional before you start, stop, or change any peptide, medication, or supplement.
FAQ
Most commonly as an anti-inflammatory — for inflammatory bowel conditions, gut healing, immune modulation, and skin inflammation. The evidence is largely from cell and animal research; human clinical data is limited.
An FDA advisory committee recommended KPV for the Section 503A Bulks List in July 2026. The vote was not drug approval, and the FDA has not made a final decision. Research-only products are not approved for human use.
KPV is used orally, topically, or by subcutaneous injection depending on the target. There is no FDA-approved product or official dosing; dosing and route should be set by a prescribing provider.
Reported effects are generally mild. Long-term human safety data does not exist, which is the main caution.
It acts inside the cell to downregulate the NF-kB pathway, the signaling system that switches on inflammatory genes, reducing inflammatory signals at the source.
It varies by use and route. Inflammatory markers like hs-CRP may shift within the first few weeks of a cycle.